Chapter | The Risks of Medical Innovation: Risk Perception and Assessment in Historical Context | 2006

BioRisk: interleukin-2 from laboratory to market in the United States and Germany

by Arthur A. Daemmrich

Keywords: Product Development; Risk and Uncertainty; Health Testing and Trials; Pharmaceutical Industry; Biotechnology Industry; United States; Germany;

Citation:

Daemmrich, Arthur A. "BioRisk: interleukin-2 from laboratory to market in the United States and Germany ." In The Risks of Medical Innovation: Risk Perception and Assessment in Historical Context, edited by Thomas Schlich and Ulrich Tröhler, 242–261. Routledge, 2006.